AD101
IND- Indications
- Atopic dermatitis
Company intelligence / Profile preview
01 Life Technology
Shenzhen, Guangdong Sheng, Chinapmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
01
Overview
The company has advanced its lead program AD‑101 targeting atopic dermatitis into Phase 1 clinical trials. It has several other programs at IND or preclinical stages focused on skin and metabolic diseases using both live biotherapeutics and small molecules derived from the human microbiome[4][3]. The company collaborates with top Chinese hospitals on over thirty clinical trials centered around the human microbiome[3].
- Therapeutic areas
- Metabolic DisordersEndocrinologyPsychiatryDermatologyGastroenterology
- Modalities
- Small molecule drugsLive biotherapeutic products (LBPs)Recombinant LBPsEngineered strains
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with nearly thirty domestic/international hospitals; joint development of lead dermatology asset with one of China’s top two dermatology medical institutions[3].
Beyond the preview
Go deeper on 01 Life Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 01 Life Technology.